Skip to content
AnalystLens
Back to CRLBalance Sheet

Charles River Laboratories International Long-Term Debt 2009-2026 | CRL

Annual FY2009–FY2025 · quarterly through Q3 FY2026

Latest annual · FY2025

$2.14B

−4.6%YoY vs FY2024Source: 10-KFY2025

From $457.4M in FY2009 to $2.14B in FY2025: 4.7× in 16 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$2.7B+6.1%$2.6B+12.3%$2.4B+11.8%Not reported
FY25$2.5B−5.6%$2.3B−3.2%$2.2B−6.1%$2.1B−4.6%
FY24$2.7B−3.0%$2.4B$2.3B−7.5%$2.2B−15.4%
FY23$2.7B+2.5%Not reported$2.5B−14.4%$2.6B−2.2%
FY22$2.7B+21.5%$3.0B+9.9%$2.9B+1.5%$2.7B+1.7%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionDeclining
CAGR

+2.1%

FY2020
$1.93B
FY2025
$2.14B

5 years selected · on the chart

Long-Term Debt History

Year-over-year comparison from 10-K annual reports

  1. $2.14B
YoY changeLargest recent move+46.9%in FY18Latest −4.6%

Long-Term Debt, period by period

PeriodValueChangeSource
FY2025$2.14B−4.6%10-K
FY2024$2.24B−15.4%10-K
FY2023$2.65B−2.2%10-K
FY2022$2.71B+1.7%10-K
FY2021$2.66B+38.0%10-K
FY2020$1.93B+4.3%10-K
FY2019$1.85B+13.0%10-K
FY2018$1.64B+46.9%10-K
FY2017$1.11B−7.7%10-K
FY2016$1.21B+42.8%10-K
FY2015$846.0M+14.2%10-K
FY2014$740.6M+15.3%10-K
FY2013$642.4M+21.9%10-K
FY2012$527.1M−25.0%10-K
FY2011$703.2M+4.9%10-K
FY2010$670.3M+46.5%10-K
FY2009$457.4M—10-K

What is long-term debt?

Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.

What is Charles River Laboratories International's current long-term debt?

Charles River Laboratories International (CRL) annual long-term debt for 2025 was $2.14B, a 4.64% decline from 2024. Charles River Laboratories International long-term debt for the quarter ending September 26, 2026 was $2.44B.

What was Charles River Laboratories International's long-term debt in 2024?

Charles River Laboratories International annual long-term debt for 2024 was $2.24B, a 15.37% decline from 2023.

What was Charles River Laboratories International's long-term debt in 2023?

Charles River Laboratories International annual long-term debt for 2023 was $2.65B, a 2.23% decline from 2022.

What is Charles River Laboratories International's 5-year long-term debt CAGR?

Charles River Laboratories International long-term debt grew at a compound annual growth rate (CAGR) of 2.06% from FY2020 to FY2025, going from $1.93B to $2.14B over 5 years.

Company
Charles River Laboratories International
Ticker
CRL
Sector
Healthcare
Industry
Services-Commercial Physical & Biological Research